167 related articles for article (PubMed ID: 17360129)
21. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y
Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
[TBL] [Abstract][Full Text] [Related]
22. Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade.
Dreier R; Grässel S; Fuchs S; Schaumburger J; Bruckner P
Exp Cell Res; 2004 Jul; 297(2):303-12. PubMed ID: 15212936
[TBL] [Abstract][Full Text] [Related]
23. Simvastatin reduces MMP-3 level in interleukin 1beta stimulated human chondrocyte culture.
Lazzerini PE; Capecchi PL; Nerucci F; Fioravanti A; Chellini F; Piccini M; Bisogno S; Marcolongo R; Laghi Pasini F
Ann Rheum Dis; 2004 Jul; 63(7):867-9. PubMed ID: 15194586
[TBL] [Abstract][Full Text] [Related]
24. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
[TBL] [Abstract][Full Text] [Related]
25. Water-soluble C60 fullerene prevents degeneration of articular cartilage in osteoarthritis via down-regulation of chondrocyte catabolic activity and inhibition of cartilage degeneration during disease development.
Yudoh K; Shishido K; Murayama H; Yano M; Matsubayashi K; Takada H; Nakamura H; Masuko K; Kato T; Nishioka K
Arthritis Rheum; 2007 Oct; 56(10):3307-18. PubMed ID: 17907184
[TBL] [Abstract][Full Text] [Related]
26. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level.
Pelletier JP; Jovanovic DV; Lascau-Coman V; Fernandes JC; Manning PT; Connor JR; Currie MG; Martel-Pelletier J
Arthritis Rheum; 2000 Jun; 43(6):1290-9. PubMed ID: 10857787
[TBL] [Abstract][Full Text] [Related]
27. Endothelin 1 promotes osteoarthritic cartilage degradation via matrix metalloprotease 1 and matrix metalloprotease 13 induction.
Roy-Beaudry M; Martel-Pelletier J; Pelletier JP; M'Barek KN; Christgau S; Shipkolye F; Moldovan F
Arthritis Rheum; 2003 Oct; 48(10):2855-64. PubMed ID: 14558091
[TBL] [Abstract][Full Text] [Related]
28. Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis.
Pelletier JP; Lajeunesse D; Jovanovic DV; Lascau-Coman V; Jolicoeur FC; Hilal G; Fernandes JC; Martel-Pelletier J
J Rheumatol; 2000 Dec; 27(12):2893-902. PubMed ID: 11128682
[TBL] [Abstract][Full Text] [Related]
29. The role of collagenolytic matrix metalloproteinases in the loss of articular cartilage in osteoarthritis.
Smith GN
Front Biosci; 2006 Sep; 11():3081-95. PubMed ID: 16720377
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinases and aggrecanases cleave aggrecan in different zones of normal cartilage but colocalize in the development of osteoarthritic lesions in STR/ort mice.
Chambers MG; Cox L; Chong L; Suri N; Cover P; Bayliss MT; Mason RM
Arthritis Rheum; 2001 Jun; 44(6):1455-65. PubMed ID: 11407708
[TBL] [Abstract][Full Text] [Related]
31. Clinical validation of an immunoaffinity LC-MS/MS assay for the quantification of a collagen type II neoepitope peptide: A biomarker of matrix metalloproteinase activity and osteoarthritis in human urine.
Li WW; Nemirovskiy O; Fountain S; Rodney Mathews W; Szekely-Klepser G
Anal Biochem; 2007 Oct; 369(1):41-53. PubMed ID: 17570334
[TBL] [Abstract][Full Text] [Related]
32. Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage.
Ohta S; Imai K; Yamashita K; Matsumoto T; Azumano I; Okada Y
Lab Invest; 1998 Jan; 78(1):79-87. PubMed ID: 9461124
[TBL] [Abstract][Full Text] [Related]
33. Calcineurin modulates the catabolic and anabolic activity of chondrocytes and participates in the progression of experimental osteoarthritis.
Yoo SA; Park BH; Yoon HJ; Lee JY; Song JH; Kim HA; Cho CS; Kim WU
Arthritis Rheum; 2007 Jul; 56(7):2299-311. PubMed ID: 17599750
[TBL] [Abstract][Full Text] [Related]
34. [Expression and regulation of matrix metalloproteases in osteoarthritic cartilage].
Dong G; Zhou H
Zhongguo Gu Shang; 2009 Feb; 22(2):156-9. PubMed ID: 19281042
[TBL] [Abstract][Full Text] [Related]
35. New molecular targets for the treatment of osteoarthritis.
Alcaraz MJ; Megías J; García-Arnandis I; Clérigues V; Guillén MI
Biochem Pharmacol; 2010 Jul; 80(1):13-21. PubMed ID: 20206140
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies.
Mastroianni CM; Liuzzi GM
Trends Mol Med; 2007 Nov; 13(11):449-59. PubMed ID: 18029231
[TBL] [Abstract][Full Text] [Related]
37. Fursultiamine, a vitamin B1 derivative, enhances chondroprotective effects of glucosamine hydrochloride and chondroitin sulfate in rabbit experimental osteoarthritis.
Kobayashi T; Notoya K; Nakamura A; Akimoto K
Inflamm Res; 2005 Jun; 54(6):249-55. PubMed ID: 15973508
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms.
Kadoglou NP; Liapis CD
Curr Med Res Opin; 2004 Apr; 20(4):419-32. PubMed ID: 15119978
[TBL] [Abstract][Full Text] [Related]
39. Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?
Murphy G; Nagase H
Nat Clin Pract Rheumatol; 2008 Mar; 4(3):128-35. PubMed ID: 18253109
[TBL] [Abstract][Full Text] [Related]
40. [Cartilage degradation in rheumatoid arthritis].
Ishiguro N
Clin Calcium; 2009 Mar; 19(3):347-54. PubMed ID: 19252244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
